Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity.
Sluder AE, Raju Paul S, Moise L, Dold C, Richard G, Silva-Reyes L, Baeten LA, Scholzen A, Reeves PM, Pollard AJ, Garritsen A, Bowen RA, De Groot AS, Rollier C, Poznansky MC. Sluder AE, et al. Among authors: scholzen a. Front Immunol. 2022 May 16;13:901372. doi: 10.3389/fimmu.2022.901372. eCollection 2022. Front Immunol. 2022. PMID: 35651616 Free PMC article.
Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine.
Scholzen A, Richard G, Moise L, Baeten LA, Reeves PM, Martin WD, Brauns TA, Boyle CM, Raju Paul S, Bucala R, Bowen RA, Garritsen A, De Groot AS, Sluder AE, Poznansky MC. Scholzen A, et al. Front Immunol. 2019 Feb 15;10:207. doi: 10.3389/fimmu.2019.00207. eCollection 2019. Front Immunol. 2019. PMID: 30828331 Free PMC article.
Coxiella burnetii Epitope-Specific T-Cell Responses in Patients with Chronic Q Fever.
Scholzen A, Richard G, Moise L, Hartman E, Bleeker-Rovers CP, Reeves PM, Raju Paul S, Martin WD, De Groot AS, Poznansky MC, Sluder AE, Garritsen A. Scholzen A, et al. Infect Immun. 2019 Sep 19;87(10):e00213-19. doi: 10.1128/IAI.00213-19. Print 2019 Oct. Infect Immun. 2019. PMID: 31331958 Free PMC article.
Application and utility of mass cytometry in vaccine development.
Reeves PM, Sluder AE, Paul SR, Scholzen A, Kashiwagi S, Poznansky MC. Reeves PM, et al. Among authors: scholzen a. FASEB J. 2018 Jan;32(1):5-15. doi: 10.1096/fj.201700325R. Epub 2017 Nov 1. FASEB J. 2018. PMID: 29092906 Review.
Mass cytometry enables highly multiplexed profiling of cellular immune responses in limited-volume samples, advancing prospects of a new era of systems immunology. The capabilities of mass cytometry offer expanded potential for deciphering immune responses to infectious di …
Mass cytometry enables highly multiplexed profiling of cellular immune responses in limited-volume samples, advancing prospects of a …
Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans.
Teirlinck AC, McCall MB, Roestenberg M, Scholzen A, Woestenenk R, de Mast Q, van der Ven AJ, Hermsen CC, Luty AJ, Sauerwein RW. Teirlinck AC, et al. Among authors: scholzen a. PLoS Pathog. 2011 Dec;7(12):e1002389. doi: 10.1371/journal.ppat.1002389. Epub 2011 Dec 1. PLoS Pathog. 2011. PMID: 22144890 Free PMC article. Clinical Trial.
Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients.
Wimmers F, de Haas N, Scholzen A, Schreibelt G, Simonetti E, Eleveld MJ, Brouwers HM, Beldhuis-Valkis M, Joosten I, de Jonge MI, Gerritsen WR, de Vries IJ, Diavatopoulos DA, Jacobs JF. Wimmers F, et al. Among authors: scholzen a. Sci Rep. 2017 Mar 7;7:43486. doi: 10.1038/srep43486. Sci Rep. 2017. PMID: 28344338 Free PMC article. Clinical Trial.
48 results